Literature DB >> 16808508

Total synthesis and biological evaluation of neodysiherbaine A and analogues.

Muneo Shoji1, Nobuyuki Akiyama, Koichi Tsubone, L Leanne Lash, James M Sanders, Geoffrey T Swanson, Ryuichi Sakai, Keiko Shimamoto, Masato Oikawa, Makoto Sasaki.   

Abstract

Dysiherbaine (1) and its congener neodysiherbaine A (2) are naturally occurring excitatory amino acids with selective and potent agonistic activity for ionotropic glutamate receptors. We describe herein the total synthesis of 2 and its structural analogues 3-8. Advanced key intermediate 16 was employed as a branching point to assemble a series of these analogues 3-8 with respect to the C8 and C9 functionalities, which would not have been accessible through manipulations of the natural product itself. The synthesis of key intermediate 16 features (i) stereocontrolled C-glycosylation to set the C6 stereocenter, (ii) concise synthesis of the bicyclic ether skeleton through chemo- and stereoselective dihydroxylation of the exo-olefin and stereoselective epoxidation of the endo-olefin, followed by epoxide ring opening/5-exo ring closure, and (iii) catalytic asymmetric hydrogenation of enamide ester to construct the amino acid appendage. A preliminary biological evaluation of analogues for their in vivo toxicity against mice and binding affinity for glutamate receptors showed that both the type and stereochemistry of the C8 and C9 functional groups affected the subtype selectivity of dysiherbaine analogues for members of the kainic acid receptor family.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808508     DOI: 10.1021/jo0605593

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  8 in total

1.  Improved synthesis and in vitro/in vivo activities of natural product-inspired, artificial glutamate analogs.

Authors:  Masato Oikawa; Minoru Ikoma; Makoto Sasaki; Martin B Gill; Geoffrey T Swanson; Keiko Shimamoto; Ryuichi Sakai
Journal:  Bioorg Med Chem       Date:  2010-04-21       Impact factor: 3.641

2.  Design and Synthesis of 2,3- trans-Proline Analogues as Ligands for Ionotropic Glutamate Receptors and Excitatory Amino Acid Transporters.

Authors:  Christian B M Poulie; Anna Alcaide; Mikkel Krell-Jørgensen; Younes Larsen; Eloi Astier; Walden E Bjørn-Yoshimoto; Feng Yi; Jed T Syrenne; Morten Storgaard; Birgitte Nielsen; Karla A Frydenvang; Anders A Jensen; Kasper B Hansen; Darryl S Pickering; Lennart Bunch
Journal:  ACS Chem Neurosci       Date:  2019-05-24       Impact factor: 4.418

Review 3.  Recent progress in neuroactive marine natural products.

Authors:  Ryuichi Sakai; Geoffrey T Swanson
Journal:  Nat Prod Rep       Date:  2014-01-17       Impact factor: 13.423

Review 4.  Ligands for ionotropic glutamate receptors.

Authors:  Geoffrey T Swanson; Ryuichi Sakai
Journal:  Prog Mol Subcell Biol       Date:  2009

5.  Novel analogs and stereoisomers of the marine toxin neodysiherbaine with specificity for kainate receptors.

Authors:  L Leanne Lash; James M Sanders; Nobuyuki Akiyama; Muneo Shoji; Pekka Postila; Olli T Pentikäinen; Makoto Sasaki; Ryuichi Sakai; Geoffrey T Swanson
Journal:  J Pharmacol Exp Ther       Date:  2007-11-21       Impact factor: 4.030

6.  Effects of alpha-Alkoxy Substitution and Conformational Constraints on 6-exo Radical Cyclizations of Hydrazones via Reversible Thiyl and Stannyl Additions.

Authors:  Gregory K Friestad; Alex K Mathies
Journal:  Tetrahedron       Date:  2007-09-17       Impact factor: 2.457

7.  Synthesis of a family of spirocyclic scaffolds: building blocks for the exploration of chemical space.

Authors:  Sarvesh Kumar; Paul D Thornton; Thomas O Painter; Prashi Jain; Jared Downard; Justin T Douglas; Conrad Santini
Journal:  J Org Chem       Date:  2013-06-26       Impact factor: 4.354

Review 8.  The direct oxidative diene cyclization and related reactions in natural product synthesis.

Authors:  Juliane Adrian; Leona J Gross; Christian B W Stark
Journal:  Beilstein J Org Chem       Date:  2016-09-30       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.